Frontiers in Oncology Seminars
Leveraging Developmental Biology to Develop Specific Immunotherapies For Childhood Cancers
John Maris, MD
Tuesday, March 16, 2021
Dr. Maris is the Giulio D’Angio Professor of Pediatrics in the Perelman School of Medicine at the University of Pennsylvania and the Children’s Hospital of Philadelphia. He is a physician-scientist who has focused for over three decades on the childhood cancer neuroblastoma with the dual goals of improving patient outcomes and also using the disease as a model to understand cancer in general. His group has discovered all of the known neuroblastoma susceptibility genes and his group has also identified many of the oncogenic drivers of the disease. Dr. Maris is an internationally recognized practicing pediatric oncologist who cares for children with refractory neuroblastoma from around the world, typically in the context of early phase clinical trials.